Walgreens

The Wall Street Journal reports that the erstwhile partners have reached a settlement of more than $25 million.

Total revenues reached $2.54 billion during the quarter, while LabCorp Diagnostics' revenues rose more than 8 percent to $1.80 billion. 

So Many Voided

In its lawsuit papers, Walgreens says Theranos voided more than 11 percent of test reports sent to Walgreens customers, according to the Wall Street Journal.

Pharmacy company Walgreens sues its former partner for $140 million in damages, according to the Wall Street Journal.

Walgreens has terminated its partnership with blood-testing firm Theranos, the Wall Street Journal reports.

Glossed Over It

The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.

Pharmacy chain Walgreens seeks to terminate its relationship with Theranos, and may be exploring one with 23andMe.

Thirty Days

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Using gene expression data combined with bioinformatic analyses, scientists at the University of Georgia and China's Jilin University are developing a urine-based protein biomarker test for gastric cancer that they hope to offer as a direct-to-consumer diagnostic.

FDA believes Pathway Genomics is offering a device that has not been cleared for marketing by the agency, and that the firm has "moved outside of the currently sanctioned boundaries for lab-developed tests by marketing a product in a retail store that asks consumers to collect the sample."

Pages

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.